JENNIFER KANNOOKADEN: Open Payments
NPI 1497401863 · MOUNT PROSPECT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 58 payments from 15 companies in 2025. Trend: 2023 $1,054 · 2024 $2,233 · 2025 $1,254
Food & beverage: $1,254
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $179 |
| Otsuka America Pharmaceutical, Inc. | 9 | $149 |
| Axsome Therapeutics, Inc. | 5 | $137 |
| Janssen Pharmaceuticals, Inc | 5 | $126 |
| Lundbeck LLC | 4 | $92 |
| Tris Pharma Inc | 4 | $83 |
| Noven Therapeutics, LLC | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 2 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
Products named: COBENFY, Auvelity, REXULTI, ABILIFY ASIMTUFII, Dyanavel XR, Xelstrym, INVEGA SUSTENNA, FANAPT.
Industry payments across IL — which companies pay providers there.
